{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:37:24Z","timestamp":1786538244104,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cullin7 (CUL7) mediates cancer progression across multiple cancer types through its regulatory role in protein ubiquitination. However, the biological function and molecular mechanisms underlying CUL7 in colon cancer remain poorly defined. Here, we demonstrate that high CUL7 expression correlates with poor prognosis in patients. Ablation of\n                    <jats:italic>CUL7<\/jats:italic>\n                    inhibited cell proliferation and migration in colon cancer cells, whereas CUL7 overexpression exhibited oncogenic properties. Moreover,\n                    <jats:italic>Cul7<\/jats:italic>\n                    -deplete mice exhibit a lower level of tumor growth. Mechanistically, CUL7 interacts with Kelch-like ECH-associated protein 1 (KEAP1) and catalyzes K29- and K48-linked polyubiquitination to promote its proteasomal degradation, which is crucial for NRF2 signaling. This leads to the decline of reactive oxygen species (ROS) and promotion of cancer growth. Importantly, the C-terminus of CUL7 is a crucial for governing KEAP1 stability and orchestrating antioxidant defense and cell growth. Clinical analysis identifies an inverse correlation between CUL7 and KEAP1 expression, and a positive correlation between CUL7 and NRF2 levels in human colon cancer. Our findings indicate that CUL7 mediates NRF2 signaling through promoting the KEAP1 ubiquitination, a mechanism that is integral to colon cancer progression. Collectively, these results establish CUL7 as a potential therapeutic target for colon cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08929-1","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T02:15:53Z","timestamp":1780884953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CUL7-mediated KEAP1 ubiquitination promotes the progression of colon cancer via NRF2 signaling"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8121-3766","authenticated-orcid":false,"given":"Le","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4252-3195","authenticated-orcid":false,"given":"Xiangpeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1207-5037","authenticated-orcid":false,"given":"Jiankang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8074-957X","authenticated-orcid":false,"given":"Jiangang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"8929_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8929_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.soc.2017.11.001","volume":"27","author":"C Wu","year":"2018","unstructured":"Wu C. Systemic Therapy for Colon Cancer. Surg Oncol Clin N Am. 2018;27:235\u201342.","journal-title":"Surg Oncol Clin N Am"},{"key":"8929_CR3","doi-asserted-by":"crossref","unstructured":"Sommer T, Wolf DH. The ubiquitin-proteasome-system. Biochim Biophys Acta. 2014;1843:1.","DOI":"10.1016\/j.bbamcr.2013.09.009"},{"key":"8929_CR4","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200390","volume":"11","author":"F Aliabadi","year":"2021","unstructured":"Aliabadi F, Sohrabi B, Mostafavi E, Pazoki-Toroudi H, Webster TJ. Ubiquitin-proteasome system and the role of its inhibitors in cancer therapy. Open Biol. 2021;11:200390.","journal-title":"Open Biol"},{"key":"8929_CR5","doi-asserted-by":"crossref","unstructured":"Kumari N, Lee KK, Jha S. Targeting the ubiquitin proteasome system in cancer. In Neoplasm. 2018: p. 203. See https:\/\/www.intechopen.com\/books\/neoplasm.","DOI":"10.5772\/intechopen.76705"},{"key":"8929_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrc3120","volume":"11","author":"S Lipkowitz","year":"2011","unstructured":"Lipkowitz S, Weissman AM. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev Cancer. 2011;11:629\u201343.","journal-title":"Nat Rev Cancer"},{"key":"8929_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrm1547","volume":"6","author":"MD Petroski","year":"2005","unstructured":"Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol. 2005;6:9\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8929_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41392-024-01778-4","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhao K, Zhou W, Kang R, Wei S, Shu Y, et al. Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer. Signal Transduct Target Ther. 2024;9:65.","journal-title":"Signal Transduct Target Ther"},{"key":"8929_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4049\/jimmunol.1900125","volume":"203","author":"Y Luo","year":"2019","unstructured":"Luo Y, Liu Y, Wu L, Ma X, Liu Q, Huang F, et al. CUL7 E3 Ubiquitin Ligase Mediates the Degradation of Activation-Induced Cytidine Deaminase and Regulates the Ig Class Switch Recombination in B Lymphocytes. J Immunol. 2019;203:269\u201381.","journal-title":"J Immunol"},{"key":"8929_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-00276-w","volume":"9","author":"L Shi","year":"2020","unstructured":"Shi L, Du D, Peng Y, Liu J, Long J. The functional analysis of Cullin 7 E3 ubiquitin ligases in cancer. Oncogenesis. 2020;9:98.","journal-title":"Oncogenesis"},{"key":"8929_CR11","first-page":"1419","volume":"41","author":"J Zhi","year":"2018","unstructured":"Zhi J, Sun J, Wang Z, Ding W. Support vector machine classifier for prediction of the metastasis of colorectal cancer. Int J Mol Med. 2018;41:1419\u201326.","journal-title":"Int J Mol Med"},{"key":"8929_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1043512","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang C, Zhao Z, Zhang Y, Liang W, Zhou C, Lin W, et al. Identification and verification of the prognostic value of CUL7 in colon adenocarcinoma. Front Immunol. 2022;13:1043512.","journal-title":"Front Immunol"},{"key":"8929_CR13","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.62347\/CHIB8915","volume":"16","author":"L Zhang","year":"2024","unstructured":"Zhang L, Hua M, Wang Y, Sun A. Comprehensive analysis of the Cullin family of genes reveals that CUL7 and CUL9 are the significant prognostic biomarkers in colorectal cancer. Am J Transl Res. 2024;16:1907\u201324.","journal-title":"Am J Transl Res"},{"key":"8929_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401\u201326.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"8929_CR15","doi-asserted-by":"publisher","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","volume":"24","author":"DD Zhang","year":"2004","unstructured":"Zhang DD, Lo SC, Cross JV, Templeton DJ, Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol. 2004;24:10941\u201353.","journal-title":"Mol Cell Biol"},{"key":"8929_CR16","doi-asserted-by":"publisher","first-page":"30091","DOI":"10.1074\/jbc.M501279200","volume":"280","author":"DD Zhang","year":"2005","unstructured":"Zhang DD, Lo SC, Sun Z, Habib GM, Lieberman MW, Hannink M. Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. J Biol Chem. 2005;280:30091\u20139.","journal-title":"J Biol Chem"},{"key":"8929_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14190-2","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Tao S, Liao L, Li Y, Li H, Li Z, et al. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway. Nat Commun. 2020;11:348.","journal-title":"Nat Commun"},{"key":"8929_CR18","doi-asserted-by":"publisher","first-page":"13561","DOI":"10.1073\/pnas.1121572109","volume":"109","author":"K Taguchi","year":"2012","unstructured":"Taguchi K, Fujikawa N, Komatsu M, Ishii T, Unno M, Akaike T, et al. Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proc Natl Acad Sci USA. 2012;109:13561\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8929_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39412-6","volume":"14","author":"C Cai","year":"2023","unstructured":"Cai C, Ma H, Peng J, Shen X, Zhen X, Yu C, et al. USP25 regulates KEAP1-NRF2 anti-oxidation axis and its inactivation protects acetaminophen-induced liver injury in male mice. Nat Commun. 2023;14:3648.","journal-title":"Nat Commun"},{"key":"8929_CR20","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1002\/1878-0261.12825","volume":"14","author":"L Shi","year":"2020","unstructured":"Shi L, Liu J, Peng Y, Zhang J, Dai X, Zhang S, et al. Deubiquitinase OTUD6A promotes proliferation of cancer cells via regulating Drp1 stability and mitochondrial fission. Mol Oncol. 2020;14:3169\u201383.","journal-title":"Mol Oncol"},{"key":"8929_CR21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1046\/j.1365-2249.2000.01094.x","volume":"119","author":"Y Araki","year":"2000","unstructured":"Araki Y, Andoh A, Fujiyama Y, Bamba T. Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws\/Ws rats. Clin Exp Immunol. 2000;119:264\u20139.","journal-title":"Clin Exp Immunol"},{"key":"8929_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1101\/gad.13.1.76","volume":"13","author":"K Itoh","year":"1999","unstructured":"Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13:76\u201386.","journal-title":"Genes Dev"},{"key":"8929_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1042\/BJ20141450","volume":"467","author":"E Bulatov","year":"2015","unstructured":"Bulatov E, Ciulli A. Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation. Biochem J. 2015;467:365\u201386.","journal-title":"Biochem J"},{"key":"8929_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.humpath.2017.07.008","volume":"67","author":"J An","year":"2017","unstructured":"An J, Liu Z, Liang Q, Pan Y, Li H, Wang R, et al. Overexpression of Rabl3 and Cullin7 is associated with pathogenesis and poor prognosis in hepatocellular carcinoma. Hum Pathol. 2017;67:146\u201351.","journal-title":"Hum Pathol"},{"key":"8929_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3727\/096504016X14519995067562","volume":"23","author":"D Zhang","year":"2016","unstructured":"Zhang D, Yang G, Li X, Xu C, Ge H. Inhibition of Liver Carcinoma Cell Invasion and Metastasis by Knockdown of Cullin7 In Vitro and In Vivo. Oncol Res. 2016;23:171\u201381.","journal-title":"Oncol Res"},{"key":"8929_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3839-7","volume":"17","author":"J An","year":"2017","unstructured":"An J, Zhang Z, Liu Z, Wang R, Hui D, Jin Y. Overexpression of Cullin7 is associated with hepatocellular carcinoma progression and pathogenesis. BMC Cancer. 2017;17:828.","journal-title":"BMC Cancer"},{"key":"8929_CR27","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.bbrc.2014.06.134","volume":"450","author":"H Guo","year":"2014","unstructured":"Guo H, Wu F, Wang Y, Yan C, Su W. Overexpressed ubiquitin ligase Cullin7 in breast cancer promotes cell proliferation and invasion via down-regulating p53. Biochem Biophys Res Commun. 2014;450:1370\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"8929_CR28","first-page":"603","volume":"39","author":"N Qiu","year":"2018","unstructured":"Qiu N, He Y, Zhang S, Hu X, Chen M, Li H. Cullin 7 is a predictor of poor prognosis in breast cancer patients and is involved in the proliferation and invasion of breast cancer cells by regulating the cell cycle and microtubule stability. Oncol Rep. 2018;39:603\u201310.","journal-title":"Oncol Rep"},{"key":"8929_CR29","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/ijc.32239","volume":"145","author":"Y Kong","year":"2019","unstructured":"Kong Y, Wang Z, Huang M, Zhou Z, Li Y, Miao H, et al. CUL7 promotes cancer cell survival through promoting Caspase-8 ubiquitination. Int J Cancer. 2019;145:1371\u201381.","journal-title":"Int J Cancer"},{"key":"8929_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/07357907.2015.1114123","volume":"34","author":"J Xi","year":"2016","unstructured":"Xi J, Zeng ST, Guo L, Feng J. High Expression of Cullin7 Correlates with Unfavorable Prognosis in Epithelial Ovarian Cancer Patients. Cancer Invest. 2016;34:130\u20136.","journal-title":"Cancer Invest"},{"key":"8929_CR31","first-page":"5362","volume":"17","author":"P Tian","year":"2018","unstructured":"Tian P, Liu D, Sun L, Sun H. Cullin7 promotes epithelial\u2011mesenchymal transition of esophageal carcinoma via the ERK\u2011SNAI2 signaling pathway. Mol Med Rep. 2018;17:5362\u20137.","journal-title":"Mol Med Rep"},{"key":"8929_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3727\/096504014X14198596979742","volume":"22","author":"X Men","year":"2015","unstructured":"Men X, Wang L, Yu W, Ju Y. Cullin7 is required for lung cancer cell proliferation and is overexpressed in lung cancer. Oncol Res. 2015;22:123\u20138.","journal-title":"Oncol Res"},{"key":"8929_CR33","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1074\/jbc.M113.520106","volume":"289","author":"H Wang","year":"2014","unstructured":"Wang H, Chen Y, Lin P, Li L, Zhou G, Liu G, et al. The CUL7\/F-box and WD repeat domain containing 8 (CUL7\/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1. J Biol Chem. 2014;289:4009\u201317.","journal-title":"J Biol Chem"},{"key":"8929_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13046-020-01553-7","volume":"39","author":"J Xu","year":"2020","unstructured":"Xu J, Zhang Z, Qian M, Wang S, Qiu W, Chen Z, et al. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-kappaB activation. J Exp Clin Cancer Res. 2020;39:59.","journal-title":"J Exp Clin Cancer Res"},{"key":"8929_CR35","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/embor.2013.173","volume":"14","author":"JR Lydeard","year":"2013","unstructured":"Lydeard JR, Schulman BA, Harper JW. Building and remodelling Cullin-RING E3 ubiquitin ligases. EMBO Rep. 2013;14:1050\u201361.","journal-title":"EMBO Rep"},{"key":"8929_CR36","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.sbi.2010.08.010","volume":"20","author":"ES Zimmerman","year":"2010","unstructured":"Zimmerman ES, Schulman BA, Zheng N. Structural assembly of cullin-RING ubiquitin ligase complexes. Curr Opin Struct Biol. 2010;20:714\u201321.","journal-title":"Curr Opin Struct Biol"},{"key":"8929_CR37","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1136\/gutjnl-2012-302091","volume":"62","author":"V Paradis","year":"2013","unstructured":"Paradis V, Albuquerque M, Mebarki M, Hernandez L, Zalinski S, Quentin S, et al. Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome. Gut. 2013;62:911\u20139.","journal-title":"Gut"},{"key":"8929_CR38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.molcel.2008.03.009","volume":"30","author":"X Xu","year":"2008","unstructured":"Xu X, Sarikas A, Dias-Santagata DC, Dolios G, Lafontant PJ, Tsai SC, et al. The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Mol Cell. 2008;30:403\u201314.","journal-title":"Mol Cell"},{"key":"8929_CR39","doi-asserted-by":"publisher","first-page":"e1001060","DOI":"10.1371\/journal.pbio.1001060","volume":"9","author":"N Litterman","year":"2011","unstructured":"Litterman N, Ikeuchi Y, Gallardo G, O\u2019Connell BC, Sowa ME, Gygi SP, et al. An OBSL1-Cul7Fbxw8 ubiquitin ligase signaling mechanism regulates Golgi morphology and dendrite patterning. PLoS Biol. 2011;9:e1001060.","journal-title":"PLoS Biol"},{"key":"8929_CR40","doi-asserted-by":"publisher","first-page":"e46485","DOI":"10.1371\/journal.pone.0046485","volume":"7","author":"C Kong","year":"2012","unstructured":"Kong C, Samovski D, Srikanth P, Wainszelbaum MJ, Charron AJ, Liu J, et al. Ubiquitination and degradation of the hominoid-specific oncoprotein TBC1D3 is mediated by CUL7 E3 ligase. PLoS One. 2012;7:e46485.","journal-title":"PLoS One"},{"key":"8929_CR41","doi-asserted-by":"publisher","first-page":"97178","DOI":"10.18632\/oncotarget.21843","volume":"8","author":"DZ Li","year":"2017","unstructured":"Li DZ, Liu SF, Zhu L, Wang YX, Chen YX, Liu J, et al. FBXW8-dependent degradation of MRFAP1 in anaphase controls mitotic cell death. Oncotarget. 2017;8:97178\u201386.","journal-title":"Oncotarget"},{"key":"8929_CR42","doi-asserted-by":"crossref","unstructured":"Shah VJ, Maddika S. CRL7(SMU1) E3 ligase complex-driven H2B ubiquitylation functions in sister chromatid cohesion by regulating SMC1 expression. J Cell Sci. 2018;131.","DOI":"10.1242\/jcs.213868"},{"key":"8929_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep40825","volume":"7","author":"PH Hsu","year":"2017","unstructured":"Hsu PH, Ma YT, Fang YC, Huang JJ, Gan YL, Chang PT, et al. Cullin 7 mediates proteasomal and lysosomal degradations of rat Eag1 potassium channels. Sci Rep. 2017;7:40825.","journal-title":"Sci Rep"},{"key":"8929_CR44","doi-asserted-by":"publisher","first-page":"E4101","DOI":"10.1073\/pnas.1719309115","volume":"115","author":"J Zou","year":"2018","unstructured":"Zou J, Ma W, Li J, Littlejohn R, Zhou H, Kim IM, et al. Neddylation mediates ventricular chamber maturation through repression of Hippo signaling. Proc Natl Acad Sci USA. 2018;115:E4101\u2013E10.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8929_CR45","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI129107","volume":"129","author":"P Wang","year":"2019","unstructured":"Wang P, Yan F, Li Z, Yu Y, Parnell SE, Xiong Y. Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development. J Clin Invest. 2019;129:4393\u2013407.","journal-title":"J Clin Invest"},{"key":"8929_CR46","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41556-024-01386-y","volume":"26","author":"L Ding","year":"2024","unstructured":"Ding L, Huwyler F, Long F, Yang W, Binz J, Wernle K, et al. Glucose controls lipolysis through Golgi PtdIns4P-mediated regulation of ATGL. Nat Cell Biol. 2024;26:552\u201366.","journal-title":"Nat Cell Biol"},{"key":"8929_CR47","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.cell.2005.09.033","volume":"123","author":"MD Petroski","year":"2005","unstructured":"Petroski MD, Deshaies RJ. Mechanism of lysine 48-linked ubiquitin-chain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34. Cell. 2005;123:1107\u201320.","journal-title":"Cell"},{"key":"8929_CR48","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrm.2016.91","volume":"17","author":"L Buetow","year":"2016","unstructured":"Buetow L, Huang DT. Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Nat Rev Mol Cell Biol. 2016;17:626\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8929_CR49","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S1097-2765(03)00234-X","volume":"11","author":"G Wu","year":"2003","unstructured":"Wu G, Xu G, Schulman BA, Jeffrey PD, Harper JW, Pavletich NP. Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. Mol Cell. 2003;11:1445\u201356.","journal-title":"Mol Cell"},{"key":"8929_CR50","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tibs.2008.12.008","volume":"34","author":"JD Hayes","year":"2009","unstructured":"Hayes JD, McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci. 2009;34:176\u201388.","journal-title":"Trends Biochem Sci"},{"key":"8929_CR51","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1053\/j.gastro.2008.06.082","volume":"135","author":"T Shibata","year":"2008","unstructured":"Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, Yamamoto M. et al. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology. 2008;135:1358\u201368.","journal-title":"Gastroenterology"},{"key":"8929_CR52","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.bbrc.2007.08.051","volume":"362","author":"P Nioi","year":"2007","unstructured":"Nioi P, Nguyen T. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem Biophys Res Commun. 2007;362:816\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"8929_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2746457","volume":"2016","author":"J Kim","year":"2016","unstructured":"Kim J, Keum YS. NRF2, a Key Regulator of Antioxidants with Two Faces towards Cancer. Oxid Med Cell Longev. 2016;2016:2746457.","journal-title":"Oxid Med Cell Longev"},{"key":"8929_CR54","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/nm.4407","volume":"23","author":"R Romero","year":"2017","unstructured":"Romero R, Sayin VI, Davidson SM, Bauer MR, Singh SX, LeBoeuf SE, et al. Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis. Nat Med. 2017;23:1362\u20138.","journal-title":"Nat Med"},{"key":"8929_CR55","first-page":"2541","volume":"18","author":"C Li","year":"2018","unstructured":"Li C, Cheng L, Wu H, He P, Zhang Y, Yang Y, et al. Activation of the KEAP1\u2011NRF2\u2011ARE signaling pathway reduces oxidative stress in Hep2 cells. Mol Med Rep. 2018;18:2541\u201350.","journal-title":"Mol Med Rep"},{"key":"8929_CR56","doi-asserted-by":"publisher","first-page":"423965","DOI":"10.1155\/2013\/423965","volume":"2013","author":"KA Jung","year":"2013","unstructured":"Jung KA, Kwak MK. Enhanced 4-hydroxynonenal resistance in KEAP1 silenced human colon cancer cells. Oxid Med Cell Longev. 2013;2013:423965.","journal-title":"Oxid Med Cell Longev"},{"key":"8929_CR57","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.molmed.2016.05.002","volume":"22","author":"S Menegon","year":"2016","unstructured":"Menegon S, Columbano A, Giordano S. The Dual Roles of NRF2 in Cancer. Trends Mol Med. 2016;22:578\u201393.","journal-title":"Trends Mol Med"},{"key":"8929_CR58","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molcel.2013.04.022","volume":"51","author":"NF Villeneuve","year":"2013","unstructured":"Villeneuve NF, Tian W, Wu T, Sun Z, Lau A, Chapman E, et al. USP15 negatively regulates Nrf2 through deubiquitination of Keap1. Mol Cell. 2013;51:68\u201379.","journal-title":"Mol Cell"},{"key":"8929_CR59","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1128\/MCB.00389-16","volume":"36","author":"T Iso","year":"2016","unstructured":"Iso T, Suzuki T, Baird L, Yamamoto M. Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells. Mol Cell Biol. 2016;36:3100\u201312.","journal-title":"Mol Cell Biol"},{"key":"8929_CR60","doi-asserted-by":"publisher","first-page":"1365.","DOI":"10.3390\/biom10101365","volume":"10","author":"L Torrente","year":"2020","unstructured":"Torrente L, Maan G, Oumkaltoum Rezig A, Quinn J, Jackson A, Grilli A. et al. High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro. Biomolecules. 2020;10:1365.","journal-title":"Biomolecules"},{"key":"8929_CR61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M Rojo de la Vega","year":"2018","unstructured":"Rojo de la Vega M, Chapman E, Zhang DD. NRF2 and the Hallmarks of Cancer. Cancer Cell. 2018;34:21\u201343.","journal-title":"Cancer Cell"},{"key":"8929_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.15430\/JCP.2021.26.1.41","volume":"26","author":"CH Song","year":"2021","unstructured":"Song CH, Kim N, Nam RH, Choi SI, Kang C, Jang JY, et al. Nuclear Factor Erythroid 2-related Factor 2 Knockout Suppresses the Development of Aggressive Colorectal Cancer Formation Induced by Azoxymethane\/Dextran Sulfate Sodium-Treatment in Female Mice. J Cancer Prev. 2021;26:41\u201353.","journal-title":"J Cancer Prev"},{"key":"8929_CR63","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.7150\/ijbs.99804","volume":"20","author":"Y Song","year":"2024","unstructured":"Song Y, Wang X, Sun Y, Yu N, Tian Y, Han J, et al. PRDX1 inhibits ferroptosis by binding to Cullin-3 as a molecular chaperone in colorectal cancer. Int J Biol Sci. 2024;20:5070\u201386.","journal-title":"Int J Biol Sci"},{"key":"8929_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111312","volume":"405","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Cai X, Ma X, Yan H, Wu Q, Tong H, et al. Delavinone elicits oxidative stress and triggers ferroptosis in colorectal cancer by inhibiting PKCdelta-mediated phosphorylation of Nrf2. Chem Biol Interact. 2025;405:111312.","journal-title":"Chem Biol Interact"},{"key":"8929_CR65","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1007\/s11095-024-03784-1","volume":"41","author":"Y Cho","year":"2024","unstructured":"Cho Y, Cha JH, Hwang Y, Kang HT, Lee JH. Ground Salicornia herbacea Powder Suppresses AOM\/DSS-induced Colon Cancer by Inhibiting Wnt\/beta-catenin Signaling and Nrf2. Pharm Res. 2024;41:2225\u201334.","journal-title":"Pharm Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08929-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08929-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08929-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:03:16Z","timestamp":1786536196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08929-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8929"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08929-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All experiments were handled in strict accordance with the guidelines and regulations of the National Institutes of Health on the use of laboratory animals. Written informed consent was obtained from all patients. Ethical approval was obtained from the Ethics Committee of The First Affiliated Hospital of Xi\u2019 an Jiaotong University for human tissue collection (No. 2025YS468) and from the Institutional Animal Care and Use Committee of Xi\u2019 an Jiaotong University for animal experiments (No. 2021-267).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"712"}}